Bryn Mawr Trust »

Mymd Pharmaceuticals shares owned by Bryn Mawr Trust

Quarter-by-quarter ownership of Mymd Pharmaceuticals (TNFA) shares owned by Bryn Mawr Trust from 13F filings

Historical chart of Bryn Mawr Trust investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by Bryn Mawr Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by Bryn Mawr Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $216 134 1.62

More positions owned by Bryn Mawr Trust

Comcast Corp Cl A (CMCSA)
Intuitive Surgical Com New (ISRG)
Apple (AAPL)
Vanguard ETF/USA Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
Vanguard Etf/usa Total Stk Mkt (VTI)
Procter & Gamble Company (PG)
iShares ETFs/USA Rus Tp200 Gr Etf (IWY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
SSgA Funds Management Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Ishares Core S&p500 Etf (IVV)
iShares ETFs/USA Msci Usa Qlt Fct (QUAL)
BlackRock Fund Advisors Msci Eafe Etf (EFA)

View all positions for Bryn Mawr Trust

Top funds holding Mymd Pharmaceuticals

Geode Capital Management
Vanguard Group
BlackRock
BlackRock
Parallel Advisors
Group One Trading
Morgan Stanley
Wells Fargo & Company
Bryn Mawr Trust
Sandy Spring Bank
Advisor Group Holdings
Harbor Investment Advisory
Royal Bank of Canada
Tower Research Capital
Newbridge Financial Services Group

View all funds holding Mymd Pharmaceuticals